Cargando…

New dual dye for vitreoretinal surgery with increased transparency

OBJECTIVES: To develop a new dye formulation for vitreoretinal surgery, which shows increased transparency for better intraoperative handling with better parameters important for use. METHODS AND ANALYSIS: A new blue dye, DDG, was synthesised and tested for toxicity and staining. Diglycerol as new d...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohr, Andreas, Cendoya, Paula, Wilinska, Joanna, Apostu, Maria, Apostu, Elena, Janku, Jori, Wilfling, Tom, Ramos, Gabriela, Al-Joumhawy, Mahmoud, Gabel, Detlef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490597/
https://www.ncbi.nlm.nih.gov/pubmed/36161825
http://dx.doi.org/10.1136/bmjophth-2022-001116
_version_ 1784793119703695360
author Mohr, Andreas
Cendoya, Paula
Wilinska, Joanna
Apostu, Maria
Apostu, Elena
Janku, Jori
Wilfling, Tom
Ramos, Gabriela
Al-Joumhawy, Mahmoud
Gabel, Detlef
author_facet Mohr, Andreas
Cendoya, Paula
Wilinska, Joanna
Apostu, Maria
Apostu, Elena
Janku, Jori
Wilfling, Tom
Ramos, Gabriela
Al-Joumhawy, Mahmoud
Gabel, Detlef
author_sort Mohr, Andreas
collection PubMed
description OBJECTIVES: To develop a new dye formulation for vitreoretinal surgery, which shows increased transparency for better intraoperative handling with better parameters important for use. METHODS AND ANALYSIS: A new blue dye, DDG, was synthesised and tested for toxicity and staining. Diglycerol as new density-increasing additive was identified, and its toxicity and lack of influence of the staining with trypan blue (TB) on a collagen membrane as model for the epiretinal membrane was determined. Transparency of the dye solution was evaluated. RESULTS: DDG is as alternative to Brilliant Blue G (BBG), with good staining properties for interna limitans models, and a good safety profile. Diglycerol is a new non-toxic additive replacing PEG3350, with reduced viscosity and no reduction in staining, allowing the reduction of TB to achieve the same staining level of the collagen membrane by 40%, with greater transparency of the dye solution and reduced viscosity. Both factors should facilitate a safe removal during surgery. CONCLUSION: A new dye preparation with improved performance in comparison to marketed combinations of BBG and TB was developed. Its reduced TB concentration and viscosity with maintained density allow better tolerance and handling.
format Online
Article
Text
id pubmed-9490597
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-94905972022-09-22 New dual dye for vitreoretinal surgery with increased transparency Mohr, Andreas Cendoya, Paula Wilinska, Joanna Apostu, Maria Apostu, Elena Janku, Jori Wilfling, Tom Ramos, Gabriela Al-Joumhawy, Mahmoud Gabel, Detlef BMJ Open Ophthalmol Original Research OBJECTIVES: To develop a new dye formulation for vitreoretinal surgery, which shows increased transparency for better intraoperative handling with better parameters important for use. METHODS AND ANALYSIS: A new blue dye, DDG, was synthesised and tested for toxicity and staining. Diglycerol as new density-increasing additive was identified, and its toxicity and lack of influence of the staining with trypan blue (TB) on a collagen membrane as model for the epiretinal membrane was determined. Transparency of the dye solution was evaluated. RESULTS: DDG is as alternative to Brilliant Blue G (BBG), with good staining properties for interna limitans models, and a good safety profile. Diglycerol is a new non-toxic additive replacing PEG3350, with reduced viscosity and no reduction in staining, allowing the reduction of TB to achieve the same staining level of the collagen membrane by 40%, with greater transparency of the dye solution and reduced viscosity. Both factors should facilitate a safe removal during surgery. CONCLUSION: A new dye preparation with improved performance in comparison to marketed combinations of BBG and TB was developed. Its reduced TB concentration and viscosity with maintained density allow better tolerance and handling. BMJ Publishing Group 2022-09-20 /pmc/articles/PMC9490597/ /pubmed/36161825 http://dx.doi.org/10.1136/bmjophth-2022-001116 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Mohr, Andreas
Cendoya, Paula
Wilinska, Joanna
Apostu, Maria
Apostu, Elena
Janku, Jori
Wilfling, Tom
Ramos, Gabriela
Al-Joumhawy, Mahmoud
Gabel, Detlef
New dual dye for vitreoretinal surgery with increased transparency
title New dual dye for vitreoretinal surgery with increased transparency
title_full New dual dye for vitreoretinal surgery with increased transparency
title_fullStr New dual dye for vitreoretinal surgery with increased transparency
title_full_unstemmed New dual dye for vitreoretinal surgery with increased transparency
title_short New dual dye for vitreoretinal surgery with increased transparency
title_sort new dual dye for vitreoretinal surgery with increased transparency
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490597/
https://www.ncbi.nlm.nih.gov/pubmed/36161825
http://dx.doi.org/10.1136/bmjophth-2022-001116
work_keys_str_mv AT mohrandreas newdualdyeforvitreoretinalsurgerywithincreasedtransparency
AT cendoyapaula newdualdyeforvitreoretinalsurgerywithincreasedtransparency
AT wilinskajoanna newdualdyeforvitreoretinalsurgerywithincreasedtransparency
AT apostumaria newdualdyeforvitreoretinalsurgerywithincreasedtransparency
AT apostuelena newdualdyeforvitreoretinalsurgerywithincreasedtransparency
AT jankujori newdualdyeforvitreoretinalsurgerywithincreasedtransparency
AT wilflingtom newdualdyeforvitreoretinalsurgerywithincreasedtransparency
AT ramosgabriela newdualdyeforvitreoretinalsurgerywithincreasedtransparency
AT aljoumhawymahmoud newdualdyeforvitreoretinalsurgerywithincreasedtransparency
AT gabeldetlef newdualdyeforvitreoretinalsurgerywithincreasedtransparency